Try for free
In the Interim...
In the Interim...

Bayesian Statistics in Clinical trials: The Past, Present, and Future

24 November 2025 1:07:17 Berry

Listen to episode

About this episode

In this episode of "In the Interim…" guest host Cooper Berry moderates a detailed discussion on the evolution and practice of Bayesian methodology in clinical trials with fellow family members Dr. Don Berry, Dr. Scott Berry, Dr. Lindsay Berry, and Dr. Nick Berry. The panel outlines the foundational principles of Bayesian decision-making in medical research, ethical debates informed by historical reports like the Belmont Report, and the shift in regulatory acceptance. Computational developments such as Markov Chain Monte Carlo (MCMC) are examined for their role in enabling applied Bayesian models. Panelists give practical accounts of implementing adaptive and platform trials, including I-SPY 2 and REMAP-CAP, and analyze challenges faced during the COVID-19 pandemic. The implications of Bayesian statistics in artificial intelligence and contemporary clinical decision-making are explored, highlighting ongoing shifts in trial design and evidence synthesis. Each discussion is grounded in direct experience and technical rigor, providing insight into both the operational realities and future trajectory of Bayesian-driven methods in clinical research.

Key Highlights:

  • Historical development of Bayesian clinical trial design and foundational influence from Leonard J. Savage to current methods
  • Ethical tension in trial conduct, referencing the Belmont Report and equipoise
  • Advances in computation and Markov Chain Monte Carlo (MCMC)
  • Regulatory frameworks for Bayesian adaptive trials, including FDA guidance
  • Implementation details from I-SPY 2 and REMAP-CAP platform trials
  • Bayesian methodology in the context of artificial intelligence, precision medicine, and future data integration

For more, visit us at https://www.berryconsultants.com/

More AI podcast episodes

Browse all →

Want to find AI jobs?

Join thousands of AI professionals finding their next opportunity

We respect your inbox. Unsubscribe at any time.

© 2026 In the Interim.... All rights reserved.

Common Questions

Frequently asked questions

Quick answers about how DevFound's AI matching, resumes, and referrals work.

DevFound's AI Copilot ingests your profile, goals, and live job data to deliver curated matches in seconds. Every match includes a resume variant, suggested referrals, and interview prep so you can act immediately. The more feedback you provide, the sharper the Copilot becomes.

AI-led job searches shrink the hours spent sifting through boards and formatting resumes. DevFound pairs automation with your personal outreach, so you reserve energy for interviews and negotiation. Traditional networking still matters, but AI gives you a lift before you even send a message.

Modern AI roles expect comfort with production-grade code, data fluency, and practical ML tooling. The strongest candidates pair deep technical chops with storytelling—translating model impact to product, GTM, and exec partners. Continuous learning keeps you ahead as stacks evolve.

DevFound rewards active seekers. Keep your profile fresh, respond to match quality prompts, and enable alerts so you never miss a role. The AI prioritizes companies and teams that align with your feedback, accelerating both introductions and interview invites.

High-density tech hubs continue to host the deepest AI talent pools, yet distributed teams are catching up fast. Use DevFound filters to hone in on onsite, hybrid, or fully remote roles and watch openings expand across time zones.

DevFound aggregates thousands of remote AI openings and flags the nuances—core hours, async culture, and visa needs—up front. The Copilot also recommends how to position your distributed work experience so hiring managers know you can thrive on a remote team.

Still have questions?

Contact Support